Category: Diseases & Conditions
Global Diseases & Conditions
-
Spring and Wire Products
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Springs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$47.0 Billion by the end ... Read More
-
Automotive Gasket and Seal
... 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Metallic Gasket, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$82.5 Billion by the ... Read More
-
Automotive Micro Switch
... at a CAGR of 3.9% over the analysis period 2024-2030. Standard Micro Switches, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$922.8 Million by the end ... Read More
-
Automotive Wiper Component Aftermarket
... 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Wiper Blade, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$6.5 Billion by the ... Read More
-
Biochemical Reagents
... CAGR of 8.7% over the analysis period 2024-2030. PCR Reagent Kits, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$6.3 Billion by the end of the ... Read More
-
Counter Terror and Public Safety Technology
... reach US$532.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Cyber Security, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More
-
Dendritic Cell Cancer Vaccine Global Market Report 2025
... cancer vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Veterinary Autoimmune Disease Therapeutics Global Market Report 2025
... disease therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Diabetes Diagnostics
... CAGR of 8.5% over the analysis period 2024-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More
-
Pain Management Devices
... at a CAGR of 7.8% over the analysis period 2024-2030. Neurostimulation Devices, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$3.5 Billion by the end of ... Read More
-
2025 Global Gaucher Disease Drugs Market Industry (2031 Outlook)
... for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology ... Read More
-
2025 Global Gaucher Disease Treatment Market Industry (2031 Outlook)
... for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology ... Read More
-
Oncology Based In-Vivo CRO
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Solid Tumors, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.2 Billion by the ... Read More
-
Recycled Carbon Fibers
... at a CAGR of 10.4% over the analysis period 2024-2030. Chopped, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$221.8 Million by the end of the ... Read More
-
Self-Leveling Concrete
... CAGR of 4.3% over the analysis period 2024-2030. Underlayment, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$7.0 Billion by the end of the analysis period. ... Read More
-
Underwater Concrete
... CAGR of 6.9% over the analysis period 2024-2030. Aggregates, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$137.8 Billion by the end of the analysis period. ... Read More
-
Anti-Malarial Medicines
... CAGR of 2.6% over the analysis period 2024-2030. Antifolate Compounds, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$462.8 Million by the end of the analysis ... Read More
-
Ablation Technologies
... CAGR of 9.7% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$3.7 Billion by the end of the analysis ... Read More
-
Building Panels
... CAGR of 5.7% over the analysis period 2024-2030. Residential, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$166.6 Billion by the end of the analysis period. ... Read More
-
Computer Aided Engineering (CAE)
... 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Finite Element Analysis (fea), one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$12.6 Billion ... Read More
-
Anti-Obesity Drugs
... CAGR of 8.7% over the analysis period 2024-2030. Prescription Drugs, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$4.9 Billion by the end of the analysis ... Read More
-
Fibromyalgia Therapeutics
... CAGR of 2.9% over the analysis period 2024-2030. Antiepileptics, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More
-
Radiofrequency Ablation Devices for Pain Management
... reach US$1.4 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Disposable Products, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach ... Read More
-
Walnut
... 2.9% over the analysis period 2024-2030. Black Walnuts, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$570.1 Million by the end of the analysis period. Growth ... Read More
-
Women's Health Rehabilitation Products
... 2030, growing at a CAGR of 1.2% over the analysis period 2024-2030. Orthopedic Rehabilitation Products, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$731.9 Million by ... Read More
Research Assistance
